IHC analysis of tumor tissues from PBS control and p53-LNP-treated groups revealed that the latter had increased expression of p53 and its downstream target, PUMA, demonstrating that pro-apoptotic pathways were activated because of the therapy (Figure 3J-M). This evidence concerns the gene TP53 and neoplasm.